Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).

NCT00032747 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
338
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi